Literature DB >> 23774819

Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism.

Makoto Kuro-o1.   

Abstract

High concentrations of extracellular phosphate are toxic to cells. Impaired urinary phosphate excretion increases serum phosphate level and induces a premature-ageing phenotype. Urinary phosphate levels are increased by dietary phosphate overload and might induce tubular injury and interstitial fibrosis. Extracellular phosphate exerts its cytotoxic effects by forming insoluble nanoparticles with calcium and fetuin-A; these nanoparticles are referred to in this Review as calciprotein particles. Calciprotein particles are highly bioactive ligands that can induce various cellular responses, including the osteogenic transformation of vascular smooth muscle cells and cell death of vascular endothelial cells and renal tubular epithelial cells. Calciprotein particles are detected in the serum of animal models of kidney disease and in patients with chronic kidney disease (CKD) and might be associated with a (mal)adaptation of the endocrine axes mediated by fibroblast growth factors and Klothos that regulate phosphate homeostasis and ageing. These observations raise the possibility that calciprotein particles contribute to the pathogenesis of CKD. This theory, if verified, is expected to provide novel diagnostic markers and therapeutic targets in CKD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23774819     DOI: 10.1038/nrneph.2013.111

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  123 in total

1.  p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.

Authors:  L Chin; S E Artandi; Q Shen; A Tam; S L Lee; G J Gottlieb; C W Greider; R A DePinho
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

2.  Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system.

Authors:  Hiroshi Tsujikawa; Yoko Kurotaki; Toshihiko Fujimori; Kazuhiko Fukuda; Yo-Ichi Nabeshima
Journal:  Mol Endocrinol       Date:  2003-10-03

Review 3.  Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies.

Authors:  Orlando M Gutiérrez; Myles Wolf
Journal:  Semin Dial       Date:  2010-06-14       Impact factor: 3.455

4.  High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease.

Authors:  Valeriu Cebotaru; Sadhana Kaul; Olivier Devuyst; Hui Cai; Lorraine Racusen; William B Guggino; Sandra E Guggino
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

5.  Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.

Authors:  Tijana Krajisnik; Hannes Olauson; Majd A I Mirza; Per Hellman; Göran Akerström; Gunnar Westin; Tobias E Larsson; Peyman Björklund
Journal:  Kidney Int       Date:  2010-08-04       Impact factor: 10.612

6.  p53 mutant mice that display early ageing-associated phenotypes.

Authors:  Stuart D Tyner; Sundaresan Venkatachalam; Jene Choi; Stephen Jones; Nader Ghebranious; Herbert Igelmann; Xiongbin Lu; Gabrielle Soron; Benjamin Cooper; Cory Brayton; Sang Hee Park; Timothy Thompson; Gerard Karsenty; Allan Bradley; Lawrence A Donehower
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

Review 7.  Liver metabolism in CRF.

Authors:  Miroslaw J Smogorzewski; Shaul G Massry
Journal:  Am J Kidney Dis       Date:  2003-03       Impact factor: 8.860

8.  Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition.

Authors:  Ricardo Villa-Bellosta; Víctor Sorribas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-12       Impact factor: 8.311

9.  Renal toxicity of phosphate in rats.

Authors:  L L Haut; A C Alfrey; S Guggenheim; B Buddington; N Schrier
Journal:  Kidney Int       Date:  1980-06       Impact factor: 10.612

10.  Calcium deficiency reduces circulating levels of FGF23.

Authors:  María E Rodriguez-Ortiz; Ignacio Lopez; Juan R Muñoz-Castañeda; Julio M Martinez-Moreno; Alan Peralta Ramírez; Carmen Pineda; Antonio Canalejo; Philippe Jaeger; Escolastico Aguilera-Tejero; Mariano Rodriguez; Arnold Felsenfeld; Yolanda Almaden
Journal:  J Am Soc Nephrol       Date:  2012-05-10       Impact factor: 10.121

View more
  84 in total

1.  Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.

Authors:  Yu Ah Hong; Ji Hee Lim; Min Young Kim; Yaeni Kim; Keun Suk Yang; Byung Ha Chung; Sungjin Chung; Bum Soon Choi; Chul Woo Yang; Yong-Soo Kim; Yoon Sik Chang; Cheol Whee Park
Journal:  Clin Exp Nephrol       Date:  2014-04-01       Impact factor: 2.801

Review 2.  Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.

Authors:  David M Charytan; Steven Fishbane; Jolanta Malyszko; Peter A McCullough; David Goldsmith
Journal:  Am J Kidney Dis       Date:  2015-02-26       Impact factor: 8.860

3.  NH4Cl Treatment Prevents Tissue Calcification in Klotho Deficiency.

Authors:  Christina B Leibrock; Ioana Alesutan; Jakob Voelkl; Tatsiana Pakladok; Diana Michael; Erwin Schleicher; Zahra Kamyabi-Moghaddam; Leticia Quintanilla-Martinez; Makoto Kuro-o; Florian Lang
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

4.  Klotho suppresses high phosphate-induced osteogenic responses in human aortic valve interstitial cells through inhibition of Sox9.

Authors:  Fei Li; Qingzhou Yao; Lihua Ao; Joseph C Cleveland; Nianguo Dong; David A Fullerton; Xianzhong Meng
Journal:  J Mol Med (Berl)       Date:  2017-03-22       Impact factor: 4.599

Review 5.  The FGF23 and Klotho system beyond mineral metabolism.

Authors:  Makoto Kuro-O
Journal:  Clin Exp Nephrol       Date:  2016-11-12       Impact factor: 2.801

6.  Biomarkers Associated with Vascular Calcification in Peritoneal Dialysis.

Authors:  Juan C Ramirez-Sandoval; Ivan Casanova; Alejandro Villar; F Enrique Gomez; Cristino Cruz; Ricardo Correa-Rotter
Journal:  Perit Dial Int       Date:  2015-08-20       Impact factor: 1.756

Review 7.  Kidney disease and obesity: epidemiology, mechanisms and treatment.

Authors:  Niels Olsen Saraiva Câmara; Kunitoshi Iseki; Holly Kramer; Zhi-Hong Liu; Kumar Sharma
Journal:  Nat Rev Nephrol       Date:  2017-01-16       Impact factor: 28.314

Review 8.  The Utility of Biomarkers in Osteoporosis Management.

Authors:  Patrick Garnero
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

9.  p38MAPK controls fibroblast growth factor 23 (FGF23) synthesis in UMR106-osteoblast-like cells and in IDG-SW3 osteocytes.

Authors:  F Ewendt; M Föller
Journal:  J Endocrinol Invest       Date:  2019-06-14       Impact factor: 4.256

10.  Hydrogen Sulfide and the Kidney.

Authors:  Balakuntalam S Kasinath; Hak Joo Lee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.